Salvage peroral endoscopic myotomy is a promising treatment for achalasia following a myotomy failure
Zhao-Chao Zhang,Jia-Qi Xu,Xin-Yang Liu,Hai-Ting Pan,Shi-Yao Chen,Yun-Shi Zhong,Yi-Qun Zhang,Wei-Feng Chen,Li-Li Ma,Jian-Wei Hu,Ming-Yan Cai,Wen-Zheng Qin,Quan-Lin Li,Ping-Hong Zhou
DOI: https://doi.org/10.1016/j.gie.2023.04.2093
IF: 10.396
2023-05-01
Gastrointestinal Endoscopy
Abstract:BACKGROUND AND AIMS: Reintervention modalities following myotomy failure in achalasia patients have yet to be established. The efficacy and safety of salvage peroral endoscopic myotomy (POEM) for treatment of achalasia following a myotomy failure were evaluated in the study.METHOD: Between August 2011 to August 2021, at the Endoscopy Center of Zhongshan Hospital, 219 achalasia patients who had previously undergone a myotomy underwent a salvage POEM and were thus retrospectively enrolled in this study. After propensity score matching (PSM), operation-related parameters were compared between the salvage POEM group and the naïve POEM group. Subgroup analysis was performed between patients with previous heller myotomy (HM) and patients with previous POEM.RESULT: With similar baseline characteristics between both groups after PSM, the salvage POEM group presented with shorter tunnel length (11.8±2.2 vs. 12.8±0.9, p<0.0001) and myotomy length (9.8±2.0 vs. 10.4±1.0, p<0.0001) than the naïve POEM group. There were no significant differences in procedure-related adverse events (AEs) between patients of salvage POEM and naïve POEM. The primary outcome of treatment success occurred in 175 of 193 patients (90.7%) in salvage POEM group vs. 362 of 374 patients (96.8%) in naïve POEM group (p = 0.0046). Significantly higher rate of clinical failures were observed at the 2-year and 5-year follow-ups in the previous HM subgroup than the previous POEM subgroup (p = 0.0433, p = 0.0230, respectively).CONCLUSION: Salvage POEM following a previous myotomy failure, especially after POEM failure, is a promising treatment option as it has a durable clinical relief rate.
gastroenterology & hepatology